Diagnosis Evaluation Made by Artificial Inteligence in Response to a Request Made by General Praticioner on OMNIDOC to the Dermatologist of the CHU of Nice. A Comparison of This Response by the One Made by the Dermatologist.

Evaluation of the Contribution of Artificiel Inteligence on a Dermatologist Tele -Expertise Request Made by General Praticioner : a Retrospective and Single-center Study.

The First part of the study will be the inclusion of our patients (those for whom a tele-expertise request has been made by their general practitioner on the OMNIDOC platform between the 1st of May 2024 and the 31st of December 2025. ) After that, the team will investigate the non opposition patient to the use of their personal information.

Subsequently, the clinical study will focus on comparing the diagnosis made by chat gpt expert and a dermatologist from the University Hospital of Nice to a request of dermatology tele-expertise made by general praticioner on OMNIDOC

Study Overview

• Status: Enrolling by invitation
• Conditions: Skin Diseases; Artificial Intelligence
• Intervention / Treatment: Other: The diagnosis made by Chat Gpt

• Study Type: Observational
• Enrollment (Estimated): 1000

Contacts and Locations

Study Locations

• France
  • Alpes Maritimes
    • Nice, Alpes Maritimes, France, 06000
      • Chu de Nice

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Adult patient for whom a tele-expertise request has ben made by their general practitioner on the OMNIDOC platform between the 1st of May 2024 and the 31st of December 2025.

Description

Inclusion Criteria:

• Adult with a request on OMNIDOC made by their general practitioner.
• Adult not opposed Social Security affiliation.
• Diagnosis made by a dermatologist.

Exclusion Criteria:

• Pediatric case.
• Unusable image.
• Absence of diagnosis made by a dermatologist.

Study Plan

How is the study designed?

Number of groups / cohorts

3

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Expert opinion; The expert had provided a diagnosis and a support based on the guideline in France	Other: The diagnosis made by Chat Gpt; The expert had provided a diagnosis and a support based on the guideline in France
chatGPT opinion; ChatGPT will provide a diagnosis and the support based on the guideline in France	Other: The diagnosis made by Chat Gpt; The expert had provided a diagnosis and a support based on the guideline in France
Specialized AI opinion; Specialised IA will provide a diagnosis and the support based on the guideline in France	Other: The diagnosis made by Chat Gpt; The expert had provided a diagnosis and a support based on the guideline in France

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Compare the diagnoses offered by artificial intelligence to those proposed by the experts on requests for tele-expertise.	Check the correspondence between the diagnosis made by the expert and the artificial intelligence on the photos, the diagnosis and supports.	From 01 May 2025 - 31 December 2026

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Compare the support and response times offered by artificial intelligence to those offered by experts for dermatology tele-expertise requests.	Check the consistency between the expert's instructions and the timeframe for intervention, and the information provided by the two artifical intelligence by The photos, the diagnosis and supports	From 01 May 2025 - 31 December 2026
Compare the differences between the responses offered by chatGPT and the specific dermatologic artificial intelligence	Compare the differences between the responses offered by chatGPT and the specific dermatologic artificial intelligence by the photos, the diagnosis and supports	From 01 May 2025 - 31 December 2026

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire de Nice

Study record dates

Study Major Dates

• Study Start (Estimated): January 1, 2026
• Primary Completion (Estimated): June 30, 2026
• Study Completion (Estimated): June 30, 2026

Study Registration Dates

• First Submitted: December 24, 2025
• First Submitted That Met QC Criteria: January 9, 2026
• First Posted (Actual): January 14, 2026

Study Record Updates

• Last Update Posted (Actual): January 14, 2026
• Last Update Submitted That Met QC Criteria: January 9, 2026
• Last Verified: December 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Skin and Connective Tissue Diseases; Skin Diseases
• Other Study ID Numbers: 25MedInterne01

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No